Abattis Bioceuticals Corp. engages in the aggregation, integration, and investment in agricultural technologies and biotechnology services for the legal cannabis industry developing in Canada. It produces markets and licenses proprietary ingredients and formulas for use in the biopharma, nutraceutical, cosmetic, and animal nutrition markets. The company was founded on June 30, 1997 and is headquartered in Vancouver, Canada.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Abattis Bioceuticals Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Abattis Bioceuticals Corp market cap is $500.00.
What is the 52-week high for Abattis Bioceuticals Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Abattis Bioceuticals Corp 52 week high is $0.00 as of September 10, 2025.
What is the 52-week low for Abattis Bioceuticals Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Abattis Bioceuticals Corp 52 week low is $0.00 as of September 10, 2025.
What is the 50-day moving average of Abattis Bioceuticals Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Abattis Bioceuticals Corp 50-day moving average is $0.00.